Basilea Pharmaceutica Ltd. Logo


  • Hebeisen P, Heinze-Krauss I, Angehrn P, Hohl P, Page MG, Then RL. In vitro and in vivo properties of Ro 63-9141, a novel broad-spectrum cephalosporin with activity against methicillin-resistant staphylococci. Antimicrob Agents Chemother. 2001; 45(3): 825–36.
  • Bowker KE, Wootton M, Holt HA and MacGowan AP. In Vitro Activity of Ro 63-9141, a Novel Broad Spectrum Pyrolidinone Cephalosporin: Activity Against Clinically Significant Anaerobes. 38th ICAAC 1998. Poster F-020.
  • Hebeisen P, Goetschi E, Gross G, Heinze-Krauss I, Hubschwerlen C, Schmitt-Hoffmann AH, Theil F-P, Specklin J-L. Synthesis, Physicochemical and Pharmacokinetic Properties of Water-Soluble Prodrugs of Ro-63-9141. 38th ICAAC 1998. Poster F-026.
  • Heinze-Krauss I, Angehrn P, Charnas RL, Gubernator K, Gutknecht EM, Hubschwerlen C, Kania M, Oefner C, Page MG, Sogabe S, Specklin JL, Winkler F. Structure-based design of beta-lactamase inhibitors. 1. Synthesis and evaluation of bridged monobactams. J Med Chem. 1998; 41(21): 3961–71.
  • Hohl P, Angehrn P, Then RL, Hebeisen P, Heinze-Krauss I. Ro 63-9141, a Novel Broad-Spectrum Anti-MRSA Pyrrolidinone Cephalosporin. Part I: Activity Against Aerobic Gram-Negatives. 38th ICAAC 1998. Poster F-024.
  • Page M, Bur D, Danel F, Heinze-Krauss I, Kania M, Mensch B, Runtz V, Weiss, Winkler F. Inhibition of the Penicillin-binding Proteins of Methicillin-resistant Staphylococci by Pyrrolidinone-3-ylidenemethyl Cephems. 38th ICAAC 1998. Poster F-22.
  • Theil F-P, Schönlein P, Schenk A, Schmitt-Hoffmann A. Pharmacokinetics of the Cephalosporin Ro 63-9141 in Five Animal Species – Extrapolation to Man. 38th ICAAC 1998. Poster F-025.
  • Zbinden R, Puenter V, von Graevenitz A. Ro63-9141, a Novel Broad-Spectrum anti-MRSA Pyrrolidinone Cephalosporin. Activity against Gram-negative Nonfermenters. 38th ICAAC 1998. Poster F-019.
  • Heinze-Krauss I, Angehrn P, Guerry P, Hebeisen P, Hubschwerlen C, Kompis I, Page MG, Richter HG, Runtz V, Stalder H, Weiss U, Wie CC. Synthesis and Structure-Activity Relationship of (Lactamylvinyl) Cephalosporins Exhibiting Activity against Staphylococci, Pneumococci, and Enterococci. J Med Chem. 1996; 39(9): 1864–71.